Savara, Inc (SVRA) Covered Calls

You can sell covered calls on Savara, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for SVRA (prices last updated Wed 4:16 PM ET):

Savara, Inc (SVRA) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
2.42 -0.02 2.40 2.49 424K - 0.1B
Covered Calls For Savara, Inc (SVRA)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
Jul 19 2.5 0.15 2.34 6.4% 97.3%
Aug 16 2.5 0.10 2.39 4.2% 29.5%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Savara Inc. operates as an orphan lung disease company. Its lead product candidate includes Molgradex, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of pulmonary alveolar proteinosis; and in Phase IIa development stage for treating nontuberculous mycobacterial and lung infection. The company is also developing AeroVanc, an inhaled vancomycin that is in Phase III stage for the treatment of methicillin-resistant staphylococcus aureus lung infection in individuals living with cystic fibrosis. The company is headquartered in Austin, Texas.